CoreFirst Bank & Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$107K Sell
3,811
-686
-15% -$18.3K 0.06% 154
2025
Q4
$112K Sell
4,497
-1,500
-25% -$37.8K 0.06% 149
2025
Q3
$153K Hold
5,997
0.08% 130
2025
Q2
$145K Buy
+5,997
New +$140K 0.08% 132
2025
Q1
Sell
-8,534
Closed -$226K 284
2024
Q4
$226K Sell
8,534
-900
-10% -$24.4K 0.13% 110
2024
Q3
$273K Sell
9,434
-327
-3% -$9.54K 0.16% 106
2024
Q2
$273K Sell
9,761
-19,122
-66% -$526K 0.18% 104
2024
Q1
$802K Sell
28,883
-13,273
-31% -$368K 0.5% 46
2023
Q4
$1.21M Sell
42,156
-1,011
-2% -$30.6K 0.81% 33
2023
Q3
$1.43M Buy
43,167
+1,966
+5% +$69.5K 1.02% 24
2023
Q2
$1.51M Sell
41,201
-2,326
-5% -$90.5K 1.06% 24
2023
Q1
$1.78M Sell
43,527
-1,380
-3% -$59.6K 1.29% 17
2022
Q4
$2.3M Buy
44,907
+108
+0.2% +$5.18K 1.75% 9
2022
Q3
$1.96M Sell
44,799
-550
-1% -$26.7K 1.69% 11
2022
Q2
$2.38M Buy
45,349
+265
+0.6% +$13.5K 1.88% 10
2022
Q1
$2.33M Sell
45,084
-349
-0.8% -$18.1K 1.6% 12
2021
Q4
$2.68M Hold
45,433
1.74% 10
2021
Q3
$1.96M Buy
45,433
+683
+2% +$30.3K 1.36% 13
2021
Q2
$1.75M Sell
44,750
-683
-2% -$26.6K 1.19% 17
2021
Q1
$1.65M Hold
45,433
1.13% 18
2020
Q4
$1.67M Buy
+45,433
New +$1.67M 1.24% 16

Other funds holding PFE

CoreFirst Bank & Trust's PFE Position: Q1 2026 in Review

CoreFirst Bank & Trust reduced its Pfizer (PFE) stake by 15% in Q1 2026, selling an estimated $18.3K and leaving 3,811 shares worth $107K. The position accounts for 0.06% of the portfolio, ranked #154.

CoreFirst Bank & Trust first reported a position in PFE in Q4 2020 and has held it in 21 quarters since. The position peaked at $2.68M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • CoreFirst Bank & Trust held 3,811 shares of Pfizer worth $107K as of Q1 2026.
  • CoreFirst Bank & Trust sold 686 Pfizer shares in Q1 2026, an estimated $18.3K.
  • Pfizer made up 0.06% of CoreFirst Bank & Trust's portfolio in Q1 2026, its #154 holding.
  • CoreFirst Bank & Trust first reported a position in Pfizer in Q4 2020 and has held it in 21 quarters since.
  • CoreFirst Bank & Trust's Pfizer position peaked at $2.68M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on CoreFirst Bank & Trust's 13F filing for Q1 2026, filed 3 Jun 2026.